LONDON, November 26, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
On Monday, November 25, 2013, the S&P 500 ended the day at 1,802.48, down 0.13%; the Dow Jones Industrial Average closed at 16,072.54, up 0.05%; and the NASDAQ Composite finished at 3,994.57, up 0.07%. Shares in the medical instruments and supplies industry mostly ended on a lower note, even as the broader market fluctuated between gains and losses. The major movers in the industry included Baxter International Inc. (NYSE: BAX), Unilife Corporation (NASDAQ: UNIS), CareFusion Corporation (NYSE: CFN), and Mindray Medical International Ltd (NYSE: MR). AAAResearchReports.com initiated preliminary technical research on BAX, UNIS, CFN, and MR. These free reports are accessible by signing today at:
Baxter Intl. Inc.'s stock edged 0.13% lower on Monday, even as the broader market ended on a mixed note. The company's shares traded between $67.60 and $68.09 before ending the day at $67.69. A total of 3.58 million shares were traded, which is above the daily average volume of 3.46. Despite Monday's losses, the company's shares have gained 3.36% in the last one month, outperforming the S&P 500, which has advanced 2.43% during the same period. Further, Baxter Intl. Inc.'s stock is trading above its 50-day moving average of $66.95. The free technical analysis on BAX is available by signing up at:
On Monday, Unilife Corp.'s stock declined to finish at $3.95, which is 1.99% lower than the previous day's closing price of $4.03. The company's shares fluctuated between $3.92 and $4.20 during the trading session. A total of 2.08 million shares were traded, which is above the daily average volume of 1.49 million. Despite Monday's losses, the company's shares have surged 18.26% in the last one month and 31.23% in the previous three months, outperforming the S&P 500, which has advanced 2.43% and 8.35% during the respective periods. Additionally, Unilife Corp.'s stock is trading above its 50-day and 200-day moving averages of $3.27 and $2.91, respectively. Register now to download free research on UNIS at:
CareFusion Corp.'s stock fluctuated between $39.19 and $39.59 before ending Monday's session 0.38% lower at $39.22. A total of 0.93 million shares were traded, which is below the daily average volume of 1.47 million. Despite Monday's pullback, the company's shares have gained 1.16% in the previous three trading sessions and 9.92% in the last one month, compared to a gain of 1.19% and 8.35% in the S&P 500 during the respective periods. Furthermore, CareFusion Corp.'s stock is trading near its 52-week high of $39.65 and above its 50-day and 200-day moving averages of $38.29 and $36.27, respectively. A free report on CFN can be accessed by registering at:
On Monday, shares in Mindray Medical Intl. Ltd edged higher to end the day at $39.54, up 0.23% from the previous day's closing price of $39.45. The company's shares vacillated between $39.19 and $40.22 during the trading session. A total of 0.36 million shares were traded, which is below the daily average volume of 0.80 million. Despite Monday's gains, the company's shares have fallen by 0.68% in the previous three trading sessions, underperforming the S&P 500, which has advanced 1.19% during the same period. Moreover, Mindray Medical Intl. Ltd's stock is trading above its 50-day and 200-day moving averages of $39.44 and $39.37, respectively. Register with AAA Research Reports and download research on MR for free at:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to making mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE AAA Research Reports